Projects funded by the NCN
Targeting peripheral cannabinoid receptors CB2 as a novel therapy to treat osteoarthritis
2014/13/B/NZ7/02311
Keywords:
cannabinoid receptor type 2 (CB2) osteoarthritis pain regeneration novel therapy biomarkers
Descriptors:
- NZ7_14: Pharmacy, pharmacotherapy, pharmacology
- NZ7_4: Prevention in population health
Panel:
NZ7 - Diagnostic tools, therapies and public health: public health, epidemiology, environmental health risks and occupational medicine, medical ethics, drug discovery and therapies, pharmacology
Host institution :
INSTYTUT FARMAKOLOGII PAN
woj. małopolskie
Principal investigator (from the host institution):
dr hab. Katarzyna Starowicz-Bubak
Number of co-investigators in the project: 7
Call: OPUS 7 - announced on 2014-03-17
Amount awarded: 1 553 250 PLN
Project start date (Y-m-d): 2015-02-02
Project end date (Y-m-d): 2020-02-01
Project duration:: 60 months (the same as in the proposal)
Project status: Project settled